These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21875233)

  • 1. Introduction to the special section: contextualizing significance testing in clinical trials.
    Thompson-Brenner H
    Psychotherapy (Chic); 2011 Sep; 48(3):215-6. PubMed ID: 21875233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical significance testing and clinical trials.
    Krause MS
    Psychotherapy (Chic); 2011 Sep; 48(3):217-22. PubMed ID: 21875234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some more fundamental problems in clinical research: comment on "Statistical significance testing and clinical trials".
    Hofmann SG
    Psychotherapy (Chic); 2011 Sep; 48(3):223-4; discussion 234-6. PubMed ID: 21875235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistics and the relationship of clinical research to clinical practice.
    Khuder SA; Kahaleh B
    J Rheumatol; 2009 Feb; 36(2):219-20. PubMed ID: 19208555
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The meanings and measurement of clinical significance.
    Kazdin AE
    J Consult Clin Psychol; 1999 Jun; 67(3):332-9. PubMed ID: 10369053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [V: p values: what they do tell and what they don't...].
    Krummenauer F
    Klin Monbl Augenheilkd; 2002 Dec; 219(12):896-8. PubMed ID: 12548477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solving problems with randomized clinical trials is not enough to improve psychotherapy outcome: comments on Krause.
    Lambert MJ
    Psychotherapy (Chic); 2011 Sep; 48(3):229-30; discussion 234-6. PubMed ID: 21875237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of state of the art statistical methodology in biomedical research: the example of methodology for interim analyses in clinical trials].
    Muñoz SR; Bangdiwala SI
    Rev Med Chil; 2001 Sep; 129(9):983-8. PubMed ID: 11725478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirically supported psychosocial interventions for children: an overview.
    Lonigan CJ; Elbert JC; Johnson SB
    J Clin Child Psychol; 1998 Jun; 27(2):138-45. PubMed ID: 9648031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance.
    Kendall PC
    J Consult Clin Psychol; 1999 Jun; 67(3):283-4. PubMed ID: 10369048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rocks and hard places in psychotherapy outcome research.
    Schnurr PP
    J Trauma Stress; 2007 Oct; 20(5):779-92. PubMed ID: 17955539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the relationship between the randomized clinical trial and real-world clinical practice.
    Gottdiener WH
    Psychotherapy (Chic); 2011 Sep; 48(3):231-3; discussion 234-6. PubMed ID: 21875238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global benefit-risk assessment in designing clinical trials and some statistical considerations of the method.
    Pritchett YL; Tamura R
    Pharm Stat; 2008; 7(3):170-8. PubMed ID: 17538942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies.
    Hommel G; Bretz F; Maurer W
    Stat Med; 2007 Sep; 26(22):4063-73. PubMed ID: 17348083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.
    Sankoh AJ; D'Agostino RB; Huque MF
    Stat Med; 2003 Oct; 22(20):3133-50. PubMed ID: 14518019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.